News Conference News HFSA 2024 ‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM L.A. McKeown October 02, 2024
News Conference News HFSA 2024 Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity Todd Neale October 01, 2024
News Daily News Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement Todd Neale September 26, 2024
News Conference News ESC 2024 MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority Shelley Wood September 01, 2024
News Conference News ESC 2024 Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD Todd Neale September 01, 2024
News Conference News ESC 2024 RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board Shelley Wood August 31, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2024 Shelley Wood July 31, 2024
News Daily News Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years Yael L. Maxwell June 26, 2024
News Daily News Semaglutide Has Similar Benefits in Women and Men With HFpEF Todd Neale June 26, 2024
News Daily News Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea Michael O'Riordan June 21, 2024
News Daily News The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead Michael O'Riordan June 20, 2024
News Daily News Kidney Events High in Older Patients After HF Hospitalization L.A. McKeown May 30, 2024
News Conference News EHRA 2024 Should Conduction-System Pacing Be Top Choice for CRT? Todd Neale April 15, 2024
News Conference News ACC 2024 IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM Caitlin E. Cox April 15, 2024
News Conference News ACC 2024 Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF Michael O'Riordan April 06, 2024